These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23657501)

  • 21. Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis.
    Shu E; Yamamoto Y; Aoyama Y; Kitajima Y
    Arch Dermatol Res; 2007 Jun; 299(3):165-7. PubMed ID: 17431647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
    Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
    J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus.
    Walter E; Vielmuth F; Rotkopf L; Sárdy M; Horváth ON; Goebeler M; Schmidt E; Eming R; Hertl M; Spindler V; Waschke J
    Sci Rep; 2017 Jun; 7(1):3579. PubMed ID: 28620161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction.
    Heupel WM; Zillikens D; Drenckhahn D; Waschke J
    J Immunol; 2008 Aug; 181(3):1825-34. PubMed ID: 18641320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3.
    Tsunoda K; Ota T; Aoki M; Yamada T; Nagai T; Nakagawa T; Koyasu S; Nishikawa T; Amagai M
    J Immunol; 2003 Feb; 170(4):2170-8. PubMed ID: 12574390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro pathogenicity assay for anti-desmoglein autoantibodies in pemphigus.
    Ishii K; Amagai M
    Methods Mol Biol; 2013; 961():219-25. PubMed ID: 23325646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pemphigus Autoantibodies Induce Blistering in Human Conjunctiva.
    Vielmuth F; Rötzer V; Hartlieb E; Hirneiß C; Waschke J; Spindler V
    Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4442-4449. PubMed ID: 27750289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alteration of reactive oxygen species master transcription factor Nrf2 in keratinocytes exposed to monoclonal pathogenic antibody AK23 against desmoglein-3 in pemphigus vulgaris.
    Alabeedi FMA
    Autoimmunity; 2024 Dec; 57(1):2377138. PubMed ID: 39037929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide-mediated desmoglein 3 crosslinking prevents pemphigus vulgaris autoantibody-induced skin blistering.
    Spindler V; Rötzer V; Dehner C; Kempf B; Gliem M; Radeva M; Hartlieb E; Harms GS; Schmidt E; Waschke J
    J Clin Invest; 2013 Feb; 123(2):800-11. PubMed ID: 23298835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical studies identify non-apoptotic low-level caspase-3 as therapeutic target in pemphigus vulgaris.
    Luyet C; Schulze K; Sayar BS; Howald D; Müller EJ; Galichet A
    PLoS One; 2015; 10(3):e0119809. PubMed ID: 25748204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective endogenous cyclic adenosine 5'-monophosphate signaling triggered by pemphigus autoantibodies.
    Spindler V; Vielmuth F; Schmidt E; Rubenstein DS; Waschke J
    J Immunol; 2010 Dec; 185(11):6831-8. PubMed ID: 21037102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-desmoglein 3 (Dsg3) monoclonal antibodies deplete desmosomes of Dsg3 and differ in their Dsg3-depleting activities related to pathogenicity.
    Yamamoto Y; Aoyama Y; Shu E; Tsunoda K; Amagai M; Kitajima Y
    J Biol Chem; 2007 Jun; 282(24):17866-76. PubMed ID: 17428808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-Desmoglein Antibodies in Patients With Pemphigus Vulgaris.
    Amber KT; Valdebran M; Grando SA
    Front Immunol; 2018; 9():1190. PubMed ID: 29915578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skin.
    Berkowitz P; Chua M; Liu Z; Diaz LA; Rubenstein DS
    Am J Pathol; 2008 Dec; 173(6):1628-36. PubMed ID: 18988808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptides Targeting the Desmoglein 3 Adhesive Interface Prevent Autoantibody-induced Acantholysis in Pemphigus.
    Heupel WM; Müller T; Efthymiadis A; Schmidt E; Drenckhahn D; Waschke J
    J Biol Chem; 2009 Mar; 284(13):8589-95. PubMed ID: 19164289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of Desmoglein Binding Is Not Sufficient for Keratinocyte Dissociation in Pemphigus.
    Vielmuth F; Waschke J; Spindler V
    J Invest Dermatol; 2015 Dec; 135(12):3068-3077. PubMed ID: 26288352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ca
    Schmitt T; Egu DT; Walter E; Sigmund AM; Eichkorn R; Yazdi A; Schmidt E; Sárdy M; Eming R; Goebeler M; Waschke J
    Br J Dermatol; 2021 Sep; 185(3):595-604. PubMed ID: 33792909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens.
    Chernyavsky AI; Arredondo J; Kitajima Y; Sato-Nagai M; Grando SA
    J Biol Chem; 2007 May; 282(18):13804-12. PubMed ID: 17344213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes.
    Cirillo N; Femiano F; Gombos F; Lanza A
    FEBS Lett; 2006 May; 580(13):3276-81. PubMed ID: 16698018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pemphigus, a pathomechanism of acantholysis.
    Furue M; Kadono T
    Australas J Dermatol; 2017 Aug; 58(3):171-173. PubMed ID: 28211055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.